- Advertisement -
Clinical-stage biotech Syntara Limited (ASX: SNT) has secured firm commitments to raise $8 million through an institutional placement as part of a $10 million capital raise, with proceeds earmarked for five clinical trial readouts this calendar year and preparatory work for a Phase 2b study of…
Click here to view the original article.
